Dr Bartl Wimmer to retire as SYNLAB Group CEO in April 2018 Deputy CEO Mathieu Floreani to succeed as Group CEO from 2 April 2018
Munich, 10 January 2018 – SYNLAB Group (‘SYNLAB’ or ‘the Group’) the leading European provider of medical diagnostic services, today announces that Dr Bartl Wimmer will retire as Group Chief Executive Officer with effect from 2 April 2018. He will remain with the Group as a Senior Advisor, a Director of the SYNLAB Board and as a significant shareholder.
Name: Bartl Wimmer
Company: SYNLAB Group
Announcement Date: January 09, 2018, 11:00pm
Resignation Date: January 09, 2018, 11:00pm